Attention Laurel Patients:  The move to the new Laurel location will not take place until Tues, 5/28. Until then, please go to 7350 Van Dusen Road, Suite 370.

Clinical Trial

Trial Protocol ID XPORT-MF-044

Trial Description

A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor (JAKi)-naïve myelofibrosis and moderate thrombocytopenia

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Mohit Narang, M.D.

Disease Types

Sponsor

  • Karyopharm Therapeutics Inc.

ClinicalTrials.gov NCT ID

  • NCT05980806